ADAP - Adaptimmune projects sarcoma franchise to deliver US peak year sales up to $400M January, 04 2024 07:59 AM Adaptimmune Therapeutics plc 2024-01-04 07:59:51 ET More on Adaptimmune Seeking Alpha’s Quant Rating on Adaptimmune Historical earnings data for Adaptimmune Financial information for Adaptimmune For further details see: Adaptimmune projects sarcoma franchise to deliver US peak year sales up to $400M